EPAS1 and lung carcinoma: Similarly, lung cancers are mostly suppressed by miR-184 via EPAS1, CDC25A, and c-MYC targeting [25, 26], although chemotherapy resistance studies reveal occasional tumour-promoting roles [27, 31].